The OECD Pharmaceutical Pricing Policy project had two main objectives:
- To add to the base of information about pharmaceutical pricing policy in OECD countries and develop a taxonomy and framework for making international comparisons of policies.
- To analyse cross-national impacts and implications of policies, particularly with respect to the impacts on pharmaceutical prices paid in other countries and on pharmaceutical R&D.
El estudio completo se puede bajar libremente.
Y un análisis del mismo se puede ver en las páginas de Synaptica
No hay comentarios:
Publicar un comentario